Serial #85090572
LIVE

Serial Number

85090572

Owner

SHANDONG BUCHANG PHARMACEUTICAL INCORPORATED COMPANY

First Use Date

Jun 1, 1995

Filing Date

Jul 22, 2010

Add to watchlist:

No watchlists yet
View on USPTO

Serial #85090572 Trademark

Serial Number: 85090572 • Registration: 4177724

Serial #85090572 is a trademark filed by SHANDONG BUCHANG PHARMACEUTICAL INCORPORATED COMPANY on July 22, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SHANDONG BUCHANG PHARMACEUTICAL INCORPORATED COMPANY (4 trademarks)

NUMBER 369, ZHONGHUA WEST ROAD
HEZE CITY, SHANDONG PROVINCE , CN

Entity Type: 03

SHANDONG BUCHANG PHARMACEUTICAL CO., LTD. (4 trademarks)

NUMBER 369, ZHONGHUA WEST ROAD
HEZE CITY, SHANDONG PROVINCE , CN

Entity Type: 03

Trademark Details

Filing Date

July 22, 2010

Registration Date

July 24, 2012

First Use Anywhere

June 1, 1995

First Use in Commerce

June 15, 2010

Published for Opposition

May 8, 2012

Goods & Services

Medicines for the treatment of pain, fever, inflammation, rheumatism and gout, and use in the treatment of nervous system disease, mental disorders disease, cardiovascular system disease, respiratory system disease, digestive system disease, genito-urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecological disease and tumor; traditional Chinese medicines in the nature of Chinese patent medicines for the treatment of pain, fever, inflammation, rheumatism and gout, and use in the treatment of nervous system disease, mental disorders disease, cardiovascular system disease, respiratory system disease, digestive system disease, genito-urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecological disease and tumor; pharmaceutical preparations and medicinal herbs all for the treatment of pain, fever, inflammation, rheumatism and gout, and use in the treatment of nervous system disease, mental disorders disease, cardiovascular system disease, respiratory system disease, digestive system disease, genito-urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecological disease and tumor; raw medicines, namely, raw materials pharmaceuticals, namely, medicinal herbal extracts for medical purposes, vitamin and mineral preparations for use as ingredients in the pharmaceutical industry; biological preparations for the treatment of pain, fever, inflammation, rheumatism and gout, and use in the treatment of nervous system disease, mental disorders disease, cardiovascular system disease, respiratory system disease, digestive system disease, genito-urinary system disease, blood system disease, endocrine system disease, immune system disease, skin disease, gynecological disease and tumor; medicines for the treatment of pain in the gums and periodontia; sanitary sterilizing preparations, namely, disinfectants for medical instruments and medical cleansers for skin and wounds; solutions for contact lenses; dietetic foods adapted for medical purposes and nutritional additives for medical purposes, namely, vitamins, ginseng for medicinal use and royal jelly for medical use; dietetic food preparations adapted for medical purposes, namely, dietary and nutritional supplements, nutritional additives for medical purposes for use in foods and dietary supplements for human consumption, all for treatment of trace element deficiency; infant formula, namely, infant milk powder; air purifying preparations; veterinary preparations, namely, veterinary vaccines for anti-inflammation and pain relief; pesticides; herbicides; sanitary towels; sterile paper towel, namely, medicated pre-moistened towelettes; sticking plasters for medical purposes; medical adhesive tape; medical dressings, namely, gauze and cotton for medical purposes; surgical dressings; surgical tissues, namely, hygienic bandages; first-aid kits; fillings for teeth

Filing History

AMENDMENT CORRESPONDENCE ENTERED
Dec 16, 2024 CRAF
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 3, 2022 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 3, 2022 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 3, 2022 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 3, 2022 APRE
TEAS SECTION 8 & 9 RECEIVED
May 19, 2022 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 12, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2022 REAP
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 24, 2021 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 12, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 12, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 12, 2020 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 29, 2019 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 29, 2019 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jan 28, 2019 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Jul 30, 2018 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 26, 2018 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 17, 2018 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 24, 2017 REM1
CORRECTION UNDER SECTION 7 - PROCESSED
Feb 11, 2016 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 11, 2016 APRE
TEAS SECTION 7 REQUEST RECEIVED
Dec 21, 2015 ES7R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 21, 2015 TCCA
CORRECTION UNDER SECTION 7 - PROCESSED
Jul 22, 2014 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 2, 2013 APRE
OTQR WITHDRAWAL FROM PUBLICATION
Oct 1, 2013 WDRL
NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Sep 13, 2013 C.7C
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 13, 2013 APRE
REQUEST FOR NEW CERTIFICATE FILED
Aug 26, 2013 C.7F
TEAS SECTION 7 REQUEST RECEIVED
Aug 26, 2013 ES7R
REGISTERED-PRINCIPAL REGISTER
Jul 24, 2012 R.PR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 30, 2012 ASCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2012 NPUB
PUBLISHED FOR OPPOSITION
May 8, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 18, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 4, 2012 PREV
ASSIGNED TO LIE
Mar 29, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 27, 2012 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 9, 2011 GNFN
FINAL REFUSAL E-MAILED
Oct 9, 2011 GNFR
FINAL REFUSAL WRITTEN
Oct 9, 2011 CNFR
EXAMINER'S AMENDMENT ENTERED
Sep 19, 2011 XAEC
ASSIGNED TO LIE
Sep 18, 2011 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 18, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 18, 2011 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2011 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2011 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 10, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 9, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 10, 2010 GNRN
NON-FINAL ACTION E-MAILED
Nov 10, 2010 GNRT
NON-FINAL ACTION WRITTEN
Nov 10, 2010 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2010 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Jul 28, 2010 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 27, 2010 NWOS
NEW APPLICATION ENTERED
Jul 26, 2010 NWAP